|
881 |
Prospective multicentre randomized double-blind placebo-controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections
Enthalten in International urology and nephrology 1.10.2022: 1-8
|
|
|
|
882 |
Effects of dexmedetomidine on oxygenation and inflammatory factors in patients undergoing uvulopalatopharyngoplasty: a prospective, randomized, placebo-controlled trial
Enthalten in Sleep and breathing 27.9.2022: 1-8
|
|
|
|
883 |
Individualized Homeopathic Medicines in the Treatment of Tinea Corporis: Double-Blind, Randomized, Placebo-Controlled Trial
Enthalten in Homeopathy 19.09.2022
|
|
|
|
884 |
Individualized Homeopathic Medicines in Treatment of Hyperuricemia: Evaluation by Double-Blind, Randomized, Placebo-Controlled Trial
Enthalten in Homeopathy 19.09.2022
|
|
|
|
885 |
Efficacy and Safety of Inosine Pranobex in COVID‐19 Patients: A Multicenter Phase 3 Randomized Double‐Blind, Placebo‐Controlled Trial
Enthalten in Advanced therapeutics 16.09.2022. 11 S.
|
|
|
|
886 |
The Fibrinolytic System in Peripartum Depression
Enthalten in Seminars in thrombosis and hemostasis 16.09.2022
|
|
|
|
887 |
The effect of preoperative clindamycin in reducing early oral implant failure: a randomised placebo-controlled clinical trial
Enthalten in Clinical oral investigations 13.9.2022: 1-10
|
|
|
|
888 |
Fampridine in multiple sclerosis patients with acute phase of cervical transverse myelitis: a double-blind, randomized placebo-controlled trial
Enthalten in Neurological sciences 12.9.2022: 1-4
|
|
|
|
889 |
Efficacy and safety of tolvaptan versus placebo in the treatment of patients with autosomal dominant polycystic kidney disease: a meta-analysis
Enthalten in International urology and nephrology 7.9.2022: 1-10
|
|
|
|
890 |
Mantelzelllymphom: Die wirkungsvollste ist nicht immer die beste Therapie
Enthalten in Karger-Kompass Onkologie Bd. 9, 2022, Nr. 3: 120-121. 2 S.
|
|
Administration
